Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (1061-1070 of 5,911) with videos related to

Pageof 592
Sort By:
The Prostate|January 1, 1986
Characterization of steroid receptors in human prostate using miboleroneL R Murthy, M P Johnson, D R Rowley, et al.
The Prostate|January 1, 1986
Regional variation of cytosol androgen receptors throughout the diseased human prostate glandS P Bowman, D M Barnes, N J Blacklock, et al.
The Prostate|October 12, 2013
Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progressionEstelle Ricci, Eve Mattei, Charles Dumontet, et al.
The Prostate|July 3, 2013
Prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infectionClaire L Townes, Ased Ali, Naomi Gross, et al.
The Prostate|July 10, 2013
Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growthShancheng Ren, Moo Rim Kang, Ji Wang, et al.
The Prostate|July 2, 2013
Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitorsYue Wu, Alejandro Godoy, Faris Azzouni, et al.
The Prostate|July 12, 2013
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrenceKatharina Grupp, Franz Diebel, Hüseyin Sirma, et al.
The Prostate|July 23, 2013
Testosterone boosts for treatment of castration resistant prostate cancer: an experimental implementation of intermittent androgen deprivationPaul Thelen, Elmar Heinrich, Felix Bremmer, et al.
The Prostate|March 15, 2012
Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer modelsBushra Ateeq, Adaikkalam Vellaichamy, Scott A Tomlins, et al.
The Prostate|October 26, 2011
Gene expression profiles and differential cytoglobin expression in atrophy and adenocarcinoma of the prostateAshish P Mogal, Mark A Watson, Fatih Ozsolak, et al.
Pageof 592

Showing results (1061-1070 of 5,911) with videos related to

Sort By:
Pageof 592
The Prostate|January 1, 1986
Characterization of steroid receptors in human prostate using miboleroneL R Murthy, M P Johnson, D R Rowley, et al.
The Prostate|January 1, 1986
Regional variation of cytosol androgen receptors throughout the diseased human prostate glandS P Bowman, D M Barnes, N J Blacklock, et al.
The Prostate|October 12, 2013
Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progressionEstelle Ricci, Eve Mattei, Charles Dumontet, et al.
The Prostate|July 3, 2013
Prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infectionClaire L Townes, Ased Ali, Naomi Gross, et al.
The Prostate|July 10, 2013
Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growthShancheng Ren, Moo Rim Kang, Ji Wang, et al.
The Prostate|July 2, 2013
Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitorsYue Wu, Alejandro Godoy, Faris Azzouni, et al.
The Prostate|July 12, 2013
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrenceKatharina Grupp, Franz Diebel, Hüseyin Sirma, et al.
The Prostate|July 23, 2013
Testosterone boosts for treatment of castration resistant prostate cancer: an experimental implementation of intermittent androgen deprivationPaul Thelen, Elmar Heinrich, Felix Bremmer, et al.
The Prostate|March 15, 2012
Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer modelsBushra Ateeq, Adaikkalam Vellaichamy, Scott A Tomlins, et al.
The Prostate|October 26, 2011
Gene expression profiles and differential cytoglobin expression in atrophy and adenocarcinoma of the prostateAshish P Mogal, Mark A Watson, Fatih Ozsolak, et al.
Pageof 592